Physician profile
Tarpan Patel
NPI 1609154418
$8,096.22
in general payments reported to CMS, 2019-2025
40 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $1,187 · 2021: $287 · 2022: $1,395 · 2023: $1,998 · 2024: $1,570 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,750.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,189.87 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,058.30 | 2019-2025 | |
| Medtronic, INC. | $884.64 | 2022-2025 | Resolute Onyx, Symplicity G3, Endurant Iis |
| Boston Scientific Corporation | $758.57 | 2022-2025 | Watchman Access System, Varithena Administration Pack, General - Therapies |
| Abbott Laboratories | $664.84 | 2019-2024 | Fortify Assura, Mitraclip, Xience Skypoint |
| Angiodynamics, INC. | $450.80 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $425.09 | 2019-2025 | |
| Philips North America LLC | $319.42 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $224.37 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $209.12 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.68 | 2019-2025 | Lifevest |
| Cordis US Corp. | $166.68 | 2023 | Rain Sheath Transradial, Radial 360 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.21 | 2022-2025 | Jardiance |
| Abiomed | $137.14 | 2022-2023 | Impella |
| Janssen Pharmaceuticals, INC | $134.12 | 2022-2024 | Xarelto |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $133.83 | 2022-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $124.98 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $101.86 | 2023-2025 | Wegovy, Ozempic |
| Bausch & Lomb Americas INC. | $91.29 | 2023 | Stellaris |
| Astrazeneca Pharmaceuticals LP | $82.10 | 2019-2024 | Wainua, Farxiga, Brilinta |
| Tempus Ai, INC | $80.64 | 2025 | Egg-Af |
| Cardiva Medical, INC. | $54.54 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Cvrx, INC. | $47.80 | 2024 | Barostim Neo System |
| Terumo Medical Corporation | $43.74 | 2019-2023 | Angio-Seal |
| Actelion Pharmaceuticals US, INC. | $42.48 | 2022 | |
| Merck Sharp & Dohme LLC | $37.92 | 2022-2025 | Capvaxive, Verquvo |
| Alnylam Pharmaceuticals INC. | $36.36 | 2022-2023 | Amvuttra |
| Chiesi USA, INC. | $32.36 | 2021 | |
| Biosense Webster, INC. | $25.81 | 2025 | Carto 3 |
| Inspire Medical Systems, INC. | $25.74 | 2025 | Inspire |
| Organogenesis INC. | $24.08 | 2023 | Puraply |
| United Therapeutics Corporation | $23.07 | 2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $18.47 | 2025 | |
| Innovation Technologies INC | $17.61 | 2024 | Irrisept |
| Inari Medical, INC. | $16.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.22 | 2023 | |
| Irhythm Technologies, INC. | $16.18 | 2023 | Zio Xt Patch |
| Cook Medical LLC | $15.70 | 2021 | |
| Advanced Oxygen Therapy INC. | $11.21 | 2024 | Topical Oxygen Chamber For Extremities |
| Thrombolex, INC. | $5.68 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarpan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.